LICENSE AGREEMENTLicense Agreement • April 5th, 2019 • Bioxytran, Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledApril 5th, 2019 Company Industry JurisdictionThis License Agreement (“Agreement”) is made this 4th day of April, 2019 (the “Effective Date”), by and among Bioxytran, Inc. (“Licensee”), a Nevada corporation, and MDX Lifesciences, Inc. (“MDX”), a Delaware corporation.